SEC charges Parallax Health Sciences for making false claims about COVID-19 efforts

0
287

SEC Boston Regional Office Director Paul Levenson said, “We allege that Parallax misled investors that the company was positioned to capitalize on opportunities created by the COVID pandemic.  Such misinformation jeopardized investors at precisely the moment when investors were attempting to respond to the financial implications of a public health emergency.”

Parallax, Arena, and Bradley offered to settle the SEC complaint, which was filed in the U.S. District Court for the Southern District of New York.

Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.

Signup for the USA Herald exclusive Newsletter

Want to contribute a story? We also accept article submissions – check out our writer’s guidelines here.